‘Sputnik 2.0’: China wants to lead the world in CRISPR research

ma crispr animal monkeys x
After using CRISPR to edit a gene that disrupts circadian rhythms in a monkey, Chinese researchers then produced five clones. Image: Xinhua/Institute of Neuroscience/Chinese Academy of Sciences/Redux

China is seeing an explosion in CRISPR-based animal studies and embracing the gene-editing technology with unrivaled zest and zeal—so much so that China could soon outpace the US in CRISPR-related research papers and patents across fields such as medical research, agriculture, and industrial applications.

China’s full-speed-ahead approach on CRISPR extends beyond animal research. There are at least 20 research groups across the country using CRISPR to modify crop genes as part of a wider, technology-based push to improve agricultural output

The animal and plant-based CRISPR studies seem to be fulfilling two purposes. First, they help bolster China’s position on several of the economic, political, and technological fronts where the country is squaring off with the US. Second, gene editing offers viable solutions to some of the major issues facing the world’s most populous country.

The ‘Sputnik 2.0 race’ is far from over, and the good news is that the competition will almost invariably lead to new discoveries and solutions that can be beneficial for all of humanity. The question then becomes what access the rest of the world will have to such solutions.

Read full, original post: Inside China’s Play to Become the World’s CRISPR Superpower

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.